Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileElizabeth M. Van Cott, M.D.

TitleAssociate Professor of Pathology
InstitutionMassachusetts General Hospital
DepartmentPathology
AddressMassachusetts General Hospital
Pathology Clinical Labs, G-J 235
55 Fruit St
Boston MA 02114
Phone617/726-9468
Fax617/726-7758
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Tripathi MM, Egawa S, Wirth AG, Tshikudi DM, Van Cott EM, Nadkarni SK. Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor. Sci Rep. 2017 Aug 23; 7(1):9169. PMID: 28835607.
    View in: PubMed
  2. Van Cott EM, Roberts AJ, Dager WE. Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy". Semin Thromb Hemost. 2017 Sep; 43(6):644. PMID: 28609797.
    View in: PubMed
  3. Van Cott EM, Roberts AJ, Dager WE. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors. Semin Thromb Hemost. 2017 Apr; 43(3):270-276. PMID: 28052306.
    View in: PubMed
  4. Van Cott EM, Smock KJ, Chen D, Hsu P, Zantek ND, Meijer P. Testing for dabigatran and rivaroxaban by clinical laboratories. Am J Hematol. 2016 Nov; 91(11):E464-E467. PMID: 27458812.
    View in: PubMed
  5. Zantek ND, Hayward CP, Simcox TG, Smock KJ, Hsu P, Van Cott EM. An Assessment of the State of Current Practice in Coagulation Laboratories. Am J Clin Pathol. 2016 Sep; 146(3):378-83. PMID: 27510716.
    View in: PubMed
  6. Smock KJ, Plumhoff EA, Meijer P, Hsu P, Zantek ND, Heikal NM, Van Cott EM. Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories. Thromb Haemost. 2016 Jul 04; 116(1):50-7. PMID: 27075008.
    View in: PubMed
  7. Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016 Jan; 91(1):46-9. PMID: 26492443.
    View in: PubMed
  8. Fitzsimons MG, Vlahakes G, Makar R, Dilley J, Wright C, Van Cott EM, Murali M. Deep Hypothermic Circulatory Arrest in a Patient With Cold-Induced Urticaria. Ann Thorac Surg. 2015 Aug; 100(2):722-3. PMID: 26234851.
    View in: PubMed
  9. Zantek ND, Hsu P, Meijer P, Smock KJ, Plumhoff EA, Refaai MA, Van Cott EM. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. Int J Lab Hematol. 2015 May; 37 Suppl 1:99-107. PMID: 25976967.
    View in: PubMed
  10. Kim YA, Gosselin R, Van Cott EM. The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays. Int J Lab Hematol. 2015 Aug; 37(4):e81-4. PMID: 25515302.
    View in: PubMed
  11. Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014 Dec; 89(12):1147-50. PMID: 25293789.
    View in: PubMed
  12. Takahashi K, Ohtani K, Larvie M, Moyo P, Chigweshe L, Van Cott EM, Wakamiya N. Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC). J Thromb Thrombolysis. 2014 Oct; 38(3):331-8. PMID: 24474086.
    View in: PubMed
  13. Yeh H, Machaidze Z, Wamala I, Fraser JW, Navarro-Alvarez N, Kim K, Schuetz C, Shi S, Zhu A, Hertl M, Elias N, Farkash EA, Vagefi PA, Varma M, Smith RN, Robson SC, Van Cott EM, Sachs DH, Markmann JF. Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Xenotransplantation. 2014 Sep-Oct; 21(5):454-64. PMID: 25130043.
    View in: PubMed
  14. Branda JA, Dighe AS, Dzik W, Ferraro MJ, Flood J, Lee-Lewandrowski E, Makar R, Mandokolathur M, Rosenberg ES, Saidman S, Sluss P, Sohani AR, Stowell C, Van Cott EM, Lewandrowski KB. The practice of clinical pathology: a quantitative description of laboratory director activities at a large academic medical center. Am J Clin Pathol. 2014 Aug; 142(2):144-9. PMID: 25015853.
    View in: PubMed
  15. Crotty R, Nazarian RM, Song PI, Van Cott EM. Heparin, warfarin, or calciphylaxis? Am J Hematol. 2014 Jul; 89(7):785-6. PMID: 24470428.
    View in: PubMed
  16. Tripathi MM, Hajjarian Z, Van Cott EM, Nadkarni SK. Assessing blood coagulation status with laser speckle rheology. Biomed Opt Express. 2014 Mar 01; 5(3):817-31. PMID: 24688816; PMCID: PMC3959840.
  17. Schaefer JH, Leung W, Wu L, Van Cott EM, Lok J, Whalen M, van Leyen K, Lauer A, van Ryn J, Lo EH, Foerch C. Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation. J Cereb Blood Flow Metab. 2014 May; 34(5):870-5. PMID: 24549187; PMCID: PMC4013768.
  18. Hsu P, Zantek ND, Meijer P, Hayward CP, Brody J, Zhang X, Smock KJ, Van Cott EM. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results. Semin Thromb Hemost. 2014 Mar; 40(2):232-8. PMID: 24497117.
    View in: PubMed
  19. Smock KJ, Ledford-Kraemer MR, Meijer P, Hsu P, Van Cott EM. Proficiency testing results for heparin-induced thrombocytopenia in north america. Semin Thromb Hemost. 2014 Mar; 40(2):254-60. PMID: 24497121.
    View in: PubMed
  20. Van Cott EM. Laboratory test interpretations and algorithms in utilization management. Clin Chim Acta. 2014 Jan 01; 427:188-92. PMID: 24080245.
    View in: PubMed
  21. Arpino PA, Goeller AJ, Fatalo A, Van Cott EM. Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2015 Apr; 21(3):260-5. PMID: 23965335.
    View in: PubMed
  22. Zantek ND, Hsu P, Refaai MA, Ledford-Kraemer M, Meijer P, Van Cott EM. Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results. Int J Lab Hematol. 2013 Jun; 35(3):314-21. PMID: 23590660.
    View in: PubMed
  23. Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD. External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med. 2012 Jul; 136(7):789-95. PMID: 22742551.
    View in: PubMed
  24. Van Cott EM. Re: 24-year-old man with previously diagnosed hemophilia. Clin Chem. 2012 Jul; 58(7):1089. PMID: 22745258.
    View in: PubMed
  25. Hayward CP, Moffat KA, Plumhoff E, Timleck M, Hoffman S, Spitzer E, Van Cott EM, Meijer P. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost. 2012 Sep; 38(6):622-31. PMID: 22718255.
    View in: PubMed
  26. Baron JM, Johnson SM, Ledford-Kraemer MR, Hayward CP, Meijer P, Van Cott EM. Protein C assay performance: an analysis of North American specialized coagulation laboratory association proficiency testing results. Am J Clin Pathol. 2012 Jun; 137(6):909-15. PMID: 22586050.
    View in: PubMed
  27. Fritsma GA, Dembitzer FR, Randhawa A, Marques MB, Van Cott EM, Adcock-Funk D, Peerschke EI. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization. Am J Clin Pathol. 2012 Jun; 137(6):904-8. PMID: 22586049.
    View in: PubMed
  28. Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012 May; 87 Suppl 1:S141-5. PMID: 22473649.
    View in: PubMed
  29. Garcia D, Van Cott EM, Kouides PA. Introductory remarks for the THSNA meeting proceedings: hemostasis and thrombosis at the cutting edge. Am J Hematol. 2012 May; 87 Suppl 1:S1. PMID: 22473910.
    View in: PubMed
  30. Johnson NV, Khor B, Van Cott EM. Advances in laboratory testing for thrombophilia. Am J Hematol. 2012 May; 87 Suppl 1:S108-12. PMID: 22473489.
    View in: PubMed
  31. Hayward CP, Moffat KA, Plumhoff E, Van Cott EM. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices. Am J Hematol. 2012 May; 87 Suppl 1:S45-50. PMID: 22367923.
    View in: PubMed
  32. Peña JA, Lewandrowski KB, Lewandrowski EL, Gregory K, Baron JM, Van Cott EM. Evaluation of the i-STAT point-of-care capillary whole blood prothrombin time and international normalized ratio: comparison to the Tcoag MDAII coagulation analyzer in the central laboratory. Clin Chim Acta. 2012 Jun 14; 413(11-12):955-9. PMID: 22330876.
    View in: PubMed
  33. Grabowski EF, Curran MA, Van Cott EM. Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow device. Thromb Res. 2012 Apr; 129(4):e18-24. PMID: 22265674.
    View in: PubMed
  34. Kitchens WH, Yeh H, Van Cott EM, Elias N, Kawai T, Markmann JF, Hertl M. Protein S deficiency in a living liver donor. Transpl Int. 2012 Feb; 25(2):e23-6. PMID: 22175543.
    View in: PubMed
  35. Schlunk F, Van Cott EM, Hayakawa K, Pfeilschifter W, Lo EH, Foerch C. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke. 2012 Jan; 43(1):246-9. PMID: 21998055; PMCID: PMC3722613.
  36. Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, Steinmetz H, Schaffer CB, Lo EH, Foerch C. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation. 2011 Oct 11; 124(15):1654-62. PMID: 21911784; PMCID: PMC3724228.
  37. Saenz AJ, Johnson NV, Van Cott EM. Acquired activated protein C resistance caused by lupus anticoagulants. Am J Clin Pathol. 2011 Sep; 136(3):344-9. PMID: 21846908.
    View in: PubMed
  38. Lewandrowski EL, Van Cott EM, Gregory K, Jang IK, Lewandrowski KB. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus. Am J Clin Pathol. 2011 May; 135(5):741-8. PMID: 21502428.
    View in: PubMed
  39. Lauer A, Schlunk F, Van Cott EM, Steinmetz H, Lo EH, Foerch C. Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2011 Aug; 31(8):1736-42. PMID: 21386857; PMCID: PMC3170939.
  40. Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD. External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia. Arch Pathol Lab Med. 2011 Feb; 135(2):227-32. PMID: 21284443.
    View in: PubMed
  41. Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol. 2010 Dec; 85(12):947-50. PMID: 21108326.
    View in: PubMed
  42. Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol. 2010 Jun; 85(6):440-2. PMID: 20309856.
    View in: PubMed
  43. Van Cott EM. All that glitters is gold? Am J Hematol. 2010 Apr; 85(4):223-4. PMID: 20162542.
    View in: PubMed
  44. Takahashi K, Chang WC, Takahashi M, Pavlov V, Ishida Y, La Bonte L, Shi L, Fujita T, Stahl GL, Van Cott EM. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology. 2011 Jan-Feb; 216(1-2):96-102. PMID: 20399528; PMCID: PMC2912947.
  45. Castellone DD, Van Cott EM. Laboratory monitoring of new anticoagulants. Am J Hematol. 2010 Mar; 85(3):185-7. PMID: 20131309.
    View in: PubMed
  46. Lane AA, Van Cott EM, Dey BR. von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathy. Am J Hematol. 2010 Feb; 85(2):134-5. PMID: 20095032.
    View in: PubMed
  47. Lee-Lewandrowski E, Nichols J, Van Cott E, Grisson R, Louissaint A, Benzer T, Lewandrowski K. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol. 2009 Sep; 132(3):326-31. PMID: 19687307.
    View in: PubMed
  48. Van Cott EM. Point-of-care testing in coagulation. Clin Lab Med. 2009 Sep; 29(3):543-53. PMID: 19840686.
    View in: PubMed
  49. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009 Aug; 61(2):325-32. PMID: 19615543.
    View in: PubMed
  50. Shaikh S, Van Cott EM. The effect of argatroban on activated protein C resistance. Am J Clin Pathol. 2009 Jun; 131(6):828-33. PMID: 19461089.
    View in: PubMed
  51. Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clin Lab Med. 2009 Jun; 29(2):339-66. PMID: 19665682.
    View in: PubMed
  52. Peerschke EI, Castellone DD, Ledford-Kraemer M, Van Cott EM, Meijer P. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience. Am J Clin Pathol. 2009 Apr; 131(4):552-8. PMID: 19289591.
    View in: PubMed
  53. Foerch C, Arai K, Van Cott EM, van Leyen K, Lo EH. Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab. 2009 May; 29(5):1015-21. PMID: 19319147; PMCID: PMC3691988.
  54. Chia S, Van Cott EM, Raffel OC, Jang IK. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation. Thromb Haemost. 2009 Mar; 101(3):535-40. PMID: 19277416.
    View in: PubMed
  55. Staropoli JF, Van Cott EM, Makar RS. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance. Transfusion. 2008 Nov; 48(11):2435-41. PMID: 18673345.
    View in: PubMed
  56. Harris K, Nguyen P, Van Cott EM. Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopenia. Am J Clin Pathol. 2008 Feb; 129(2):282-6. PMID: 18208809.
    View in: PubMed
  57. Olson JD, Brandt JT, Chandler WL, Van Cott EM, Cunningham MT, Hayes TE, Kottke-Marchant KK, Makar RS, Uy AB, Wang EC. Laboratory reporting of the international normalized ratio: progress and problems. Arch Pathol Lab Med. 2007 Nov; 131(11):1641-7. PMID: 17979481.
    View in: PubMed
  58. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007 Jun; 131(6):890-901. PMID: 17550316.
    View in: PubMed
  59. Salem RO, Van Cott EM. A new automated screening assay for the diagnosis of von Willebrand disease. Am J Clin Pathol. 2007 May; 127(5):730-5. PMID: 17439831.
    View in: PubMed
  60. Cunningham MT, Brandt JT, Chandler WL, Eby CS, Hayes TE, Krishnan J, Lefkowitz JB, Olson JD, Stasik CJ, Teruya J, Van Cott EM. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2007 Apr; 33(3):250-8. PMID: 17427059.
    View in: PubMed
  61. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7. PMID: 17257993.
    View in: PubMed
  62. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med. 2007 Feb; 131(2):293-6. PMID: 17284116.
    View in: PubMed
  63. Laposata M, Van Cott EM, Lev MH. Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status. N Engl J Med. 2007 Jan 11; 356(2):174-82. PMID: 17215536.
    View in: PubMed
  64. Smogorzewska A, Brandt JT, Chandler WL, Cunningham MT, Hayes TE, Olson JD, Kottke-Marchant K, Van Cott EM. Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing. Arch Pathol Lab Med. 2006 Nov; 130(11):1605-11. PMID: 17076521.
    View in: PubMed
  65. Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7. PMID: 16875910.
    View in: PubMed
  66. Hayes TE, Brandt JT, Chandler WL, Eby CS, Kottke-Marchant K, Krishnan J, Lefkowitz JB, Olson JD, Rund CR, Van Cott EM, Cunningham MT. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2006 Jul; 32(5):499-504. PMID: 16862523.
    View in: PubMed
  67. Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21. PMID: 16860036.
    View in: PubMed
  68. Kratz A, Wood MJ, Siegel AJ, Hiers JR, Van Cott EM. Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activation. Am J Clin Pathol. 2006 Feb; 125(2):296-300. PMID: 16393676.
    View in: PubMed
  69. Kratz A, Stanganelli N, Van Cott EM. A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Arch Pathol Lab Med. 2006 Jan; 130(1):39-44. PMID: 16390236.
    View in: PubMed
  70. Gettings EM, Brush KA, Van Cott EM, Hurford WE. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Crit Care. 2006; 10(6):R161. PMID: 17109753; PMCID: PMC1794468.
  71. Refaai MA, Lukoszyk M, Hughes J, Eby CS, Van Cott EM. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming. Am J Clin Pathol. 2005 Dec; 124(6):972; author reply 973. PMID: 16416745.
    View in: PubMed
  72. Kratz A, Bengtsson HI, Casey JE, Keefe JM, Beatrice GH, Grzybek DY, Lewandrowski KB, Van Cott EM. Performance evaluation of the CellaVision DM96 system: WBC differentials by automated digital image analysis supported by an artificial neural network. Am J Clin Pathol. 2005 Nov; 124(5):770-81. PMID: 16203273.
    View in: PubMed
  73. Van Cott EM, Ledford-Kraemer M, Meijer P, Nichols WL, Johnson SM, Peerschke EI. Protein S assays: an analysis of North American Specialized Coagulation Laboratory Association proficiency testing. Am J Clin Pathol. 2005 May; 123(5):778-85. PMID: 15981819.
    View in: PubMed
  74. Arpino PA, Demirjian Z, Van Cott EM. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Pharmacotherapy. 2005 Feb; 25(2):157-64. PMID: 15767231.
    View in: PubMed
  75. Van Cott EM, Fletcher SR, Kratz A. Effects of the blood-collection tube material and long-term storage on platelet activation parameters on the ADVIA 120/2120 hematology system. Lab Hematol. 2005; 11(1):71-5. PMID: 15790555.
    View in: PubMed
  76. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med. 2004 Dec; 128(12):1424-7. PMID: 15578888.
    View in: PubMed
  77. Van Cott EM, Laposata M, Hartnett ME. Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis. 2004 Jul; 15(5):393-7. PMID: 15205587.
    View in: PubMed
  78. Comunale ME, Van Cott EM. Heparin-induced thrombocytopenia. Int Anesthesiol Clin. 2004; 42(3):27-43. PMID: 15205638.
    View in: PubMed
  79. Smith EY, Charles LA, Van Cott EM. Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol. 2004 Jan; 121(1):138-41. PMID: 14750251.
    View in: PubMed
  80. Florez JC, Ay H, Van Cott EM, Buonanno FS. Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis. 2003 May-Jun; 12(3):114-8. PMID: 17903914.
    View in: PubMed
  81. Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol. 2003 Apr; 119(4):497-504. PMID: 12710122.
    View in: PubMed
  82. Hartnett ME, Laposata M, Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol. 2003 Apr; 135(4):542-4. PMID: 12654376.
    View in: PubMed
  83. Refaai MA, Laposata M, Van Cott EM. Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Am J Clin Pathol. 2003 Jan; 119(1):61-5. PMID: 12520698.
    View in: PubMed
  84. Van Cott EM, Lewandrowski KB, Patel S, Grzybek DY, Patel HS, Fletcher SR, Kratz A. Comparison of glass K3EDTA versus plastic K2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials. Lab Hematol. 2003; 9(1):10-4. PMID: 12661823.
    View in: PubMed
  85. Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol. 2002 Dec; 118(6):856-63. PMID: 12472278.
    View in: PubMed
  86. Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med. 2002 Nov; 126(11):1281-95. PMID: 12421136.
    View in: PubMed
  87. Van Cott EM, Smith EY, Galanakis DK. Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin time. Am J Clin Pathol. 2002 Aug; 118(2):263-8. PMID: 12162688.
    View in: PubMed
  88. Van Cott EM, Soderberg BL, Laposata M. Hypercoagulability test strategies in the protein C and protein S pathway. Clin Lab Med. 2002 Jun; 22(2):391-403. PMID: 12134467.
    View in: PubMed
  89. Van Cott EM, Soderberg BL, Laposata M. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. Arch Pathol Lab Med. 2002 May; 126(5):577-82. PMID: 11958664.
    View in: PubMed
  90. Nestoridi E, Buonanno FS, Jones RM, Krishnamoorthy K, Grant PE, Van Cott EM, Grabowski EF. Arterial ischemic stroke in childhood: the role of plasma-phase risk factors. Curr Opin Neurol. 2002 Apr; 15(2):139-44. PMID: 11923626.
    View in: PubMed
  91. Van Cott E, Laposata M. Cysteine and venous thrombosis: a case report. Am J Clin Pathol. 2002 Jan; 117(1):168. PMID: 11789724.
    View in: PubMed
  92. Siegel AJ, Stec JJ, Lipinska I, Van Cott EM, Lewandrowski KB, Ridker PM, Tofler GH. Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 2001 Oct 15; 88(8):918-20, A9. PMID: 11676965.
    View in: PubMed
  93. Palmer-Toy DE, Szczepiorkowski ZM, Shih V, Van Cott EM. Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood. Clin Chem. 2001 Sep; 47(9):1704-7. PMID: 11514408.
    View in: PubMed
  94. Van Cott EM. Coagulation point-of-care testing. Clin Lab Med. 2001 Jun; 21(2):337-50. PMID: 11396087.
    View in: PubMed
  95. Laposata M, Van Cott EM. How to work up hypercoagulability. CAP Today. 2000 Jan; 14(1):24-6. PMID: 10788290.
    View in: PubMed
  96. Muszbek L, Haramura G, Cluette-Brown JE, Van Cott EM, Laposata M. The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids. Lipids. 1999; 34 Suppl:S331-7. PMID: 10419194.
    View in: PubMed
  97. Van Cott EM, Laposata M. Laboratory evaluation of hypercoagulable states. Hematol Oncol Clin North Am. 1998 Dec; 12(6):1141-66, v. PMID: 9922930.
    View in: PubMed
  98. Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998 Sep; 122(9):799-807. PMID: 9740137.
    View in: PubMed
  99. Van Cott EM, Grabowski EF. Vascular hemostasis in flowing blood in children. Semin Thromb Hemost. 1998; 24(6):583-90. PMID: 10066154.
    View in: PubMed
  100. Van Cott EM, Muszbek L, Laposata M. Fatty acid acylation of platelet proteins. Prostaglandins Leukot Essent Fatty Acids. 1997 Jul; 57(1):33-7. PMID: 9250606.
    View in: PubMed
  101. Van Cott EM. How to diagnose and manage heparin-induced thrombocytopenia. CAP Today. 1997 Mar; 11(3):50-4. PMID: 10166432.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Van Cott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_